Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 14 NOV 2012
Assessed as up-to-date: 31 MAY 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Bergner N, Monsef I, Illerhaus G, Engert A, Skoetz N. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009355. DOI: 10.1002/14651858.CD009355.pub2.
- Publication Status: New
- Published Online: 14 NOV 2012
This article has been cited by:
- 1Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology, The Lancet Oncology, 2015, 16, 7, e322, , , , , , , , , , , , , , , , , , , ,